Neuronetics Inc. (NASDAQ: STIM)
$0.6369
-0.4630 ( -42.10% ) 5.5M
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
Market Data
Open
$0.6369
Previous close
$1.1000
Volume
5.5M
Market cap
$18.82M
Day range
$0.5460 - $1.1480
52 week range
$0.5460 - $5.0699
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 18 | Aug 13, 2024 |
8-k | 8K-related | 14 | Aug 12, 2024 |
10-q | Quarterly Reports | 85 | Aug 12, 2024 |
8-k | 8K-related | 16 | Aug 12, 2024 |
8-k | 8K-related | 18 | Jul 30, 2024 |
4 | Insider transactions | 1 | Jul 22, 2024 |
4 | Insider transactions | 1 | Jul 18, 2024 |
4 | Insider transactions | 1 | Jun 06, 2024 |
8-k | 8K-related | 32 | Jun 06, 2024 |
4 | Insider transactions | 2 | Jun 05, 2024 |